Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Phase I taselisib results and a cell-free DNA assay
Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Phase I taselisib results and a cell-free DNA assay ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018
One off PSA prostate screening for men does not save lives
Prof Richard Martin - University of Bristol, Bristol, UK
One off PSA prostate screening for men does not save lives ( Prof Richard Martin - University of Bristol, Bristol, UK )
29 Mar 2018
The Integrative Cancer Epidemiology Programme
Prof Richard Martin - University of Bristol, Bristol, UK
The Integrative Cancer Epidemiology Programme ( Prof Richard Martin - University of Bristol, Bristol, UK )
29 Mar 2018
Editor’s Choice for March 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for March 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
29 Mar 2018
Management of marker negative stage II testicular cancer
Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada
Management of marker negative stage II testicular cancer ( Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada )
16 Mar 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
Expert insight: Metastatic hormone sensitive prostate cancer latest
Professor Karim Fizazi and Professor Nicholas James
Expert insight: Metastatic hormone sensitive prostate cancer latest ( Professor Karim Fizazi and Professor Nicholas James )
10 Feb 2018
Focus on non-metastatic castration resistant prostate cancer
Professor Noel Clarke and Dr Eric Small
Focus on non-metastatic castration resistant prostate cancer ( Professor Noel Clarke and Dr Eric Small )
10 Feb 2018
Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial...
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma
Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada
Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma ( Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada )
9 Feb 2018
Genetic mutations: New therapeutic avenues in metastatic prostate cancer
Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Genetic mutations: New therapeutic avenues in metastatic prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
9 Feb 2018
6-factor prognostic model for patients with advanced urothelial carcinoma
Dr Gregory Pond - McMaster University, Hamilton, Ontario
6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )
9 Feb 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation